Clinical trial · Observational
Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound
NCT06902935CI-TRIAL-00087873not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Construct a breast cancer risk prediction model based on traditional Chinese medicine four diagnostic instruments and B-ultrasound images. Ensure that the key evaluation indicators of the model reach a high level through clinical verification, so as to contribute to accurate clinical diagnosis and treatment decision-making.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Screening | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diagnosis of Breast Cancer by Traditional Chinese Medicine Four Examinations | Diagnostic Test | — | UNRESOLVED |
| Ultrasound diagnosis of breast cancer | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Case group
- description
- The patients included in the group are those whose pathological results of breast masses are malignant.
- interventionNames
- Diagnostic Test: Diagnosis of Breast Cancer by Traditional Chinese Medicine Four Examinations
- label
- Control group
- description
- The patients included in this group are those whose pathological results of breast masses are benign.
- interventionNames
- Diagnostic Test: Ultrasound diagnosis of breast cancer
Primary outcomes (9)
- measure
- Tongue appearance collection (overall tongue color)
- timeFrame
- through study completion, an average of 1 year
- description
- pale white, pale purple, light red, dark red, dark purple
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Female patients aged between 30 and 75. 2. Patients who have a mass detected by US examination, need to undergo surgery or needle biopsy, and obtain a definite pathological result. 3. Patients who have obtained complete identification results of tongue, pulse, face, and constitution through the traditional Chinese medicine four diagnostic instruments. Exclusion Criteria: \- 1. Patients with severe heart, liver, or kidney insufficiency, or other serious systemic diseases. 2\. Patients with a history of other malignant tumors. 3. Cases with poor - quality B - ultrasound images. 4. Cases with an unclear pathological diagnosis. 5. Patients with obvious lesions on the face, in the oral cavity, or on the tongue that may affect the measurement results.
References
Publications (0)
Data not yet available
No reference posted for this study.